Victoria Wolodzko Smart, Senior Vice President at Mission at Susan G. Komen, shared AstraZeneca‘s post on LinkedIn, adding:
“Prioritizing the fight against breast cancer globally is the only way we’ll ensure that no one, anywhere, dies of breast cancer. Susan G. Komen is proud to continue our advocacy for adoption of the Breast Cancer Care Quality Index (BCCQI) alongside colleagues worldwide, including Toyin Saraki, Naveena Nekkalapudi, Mary Ajango and Maira Caleffi who you’ll meet in this video.
Our thanks France Dube and AstraZeneca for the support of this critically important initiative to bring lifesaving progress to all corners of the world.”
Quoting AstraZeneca‘s post:
“As we look to the year ahead, one thing remains clear: progress in breast cancer research only matters if it reaches the women who need it most.
Last year a multidisciplinary group of international experts published the Breast Cancer Care Quality Index (BCCQI): An innovative tool designed to help countries access breast cancer policies, identify critical gaps, and shape tailored strategies for improvement, marking a significant step forward in advancing breast cancer care worldwide.”
More posts featuring Victoria Wolodzko Smart